Clinical features, pathophysiology and treatment of dementia associated with Parkinson's disease

M Emre - Handbook of clinical neurology, 2007 - Elsevier
Publisher Summary Parkinson's disease (PD), the second most common neurodegenerative
disorder after Alzheimer's disease (AD), is considered the prototypical disease of movement …

Dementia with Lewy bodies: a review

L Rampello, S Cerasa, A Alvano, V Butta… - Archives of gerontology …, 2004 - Elsevier
The dementia with Lewy bodies (DLB) is the second major type of senile, degenerative
dementia, after the Alzheimer disease (AD). It is characterized by the presence of …

Multimodality imaging of neurodegenerative disorders with a focus on multiparametric magnetic resonance and molecular imaging

JR Loftus, S Puri, SP Meyers - Insights Into Imaging, 2023 - Springer
Neurodegenerative diseases afflict a large number of persons worldwide, with the
prevalence and incidence of dementia rapidly increasing. Despite their prevalence, clinical …

Neuroimaging of dementia with Lewy bodies

JP Taylor, J O'Brien - Neuroimaging Clinics, 2012 - neuroimaging.theclinics.com
Dementia with Lewy bodies (DLB) is a relative newcomer to the field of late-life dementia,
and its late emergence as an independent disease entity can in part be explained by its …

Imaging in dementia with Lewy bodies: a review

PM Kemp, C Holmes - Nuclear medicine communications, 2007 - journals.lww.com
This review discusses the role of functional and structural imaging in patients with suspected
dementia with Lewy bodies, with particular emphasis on SPECT and PET dopaminergic and …

Autonomic dysfunction in mild cognitive impairment: a transcranial Doppler study

GP Anzola, S Galluzzi, S Mazzucco… - Acta neurologica …, 2011 - Wiley Online Library
Anzola GP, Galluzzi S, Mazzucco S, Frisoni GB. Autonomic dysfunction in mild cognitive
impairment: a transcranial Doppler study. Acta Neurol Scand: 2011: 124: 403–409.© 2011 …

123I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms

M Catalan, F Dore, P Polverino… - Movement Disorders …, 2021 - Wiley Online Library
ABSTRACT Background 123I‐Metaiodobenzylguanidine (123I‐MIBG) myocardial
scintigraphy is a useful technique to differentiate Parkinson's disease (PD) from atypical …

Efficacy of olfactory and pareidolia tests compared with that of indicative biomarkers in diagnosis of dementia with Lewy bodies

Y Inagawa, H Kanetaka, A Tsugawa, S Sakurai… - Frontiers in …, 2020 - frontiersin.org
Purpose: Although olfactory decline and visual hallucinations are useful in distinguishing
dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) in a clinical setting, neither …

[HTML][HTML] 123I-Meta-iodobenzylguanidine sympathetic imaging: Standardization and application to neurological diseases

K Nakajima, M Yamada - Chonnam Medical Journal, 2016 - ncbi.nlm.nih.gov
Abstract 123 I-meta-iodobenzylguanidine (MIBG) has become widely applied in Japan since
its introduction to clinical cardiology and neurology practice in the 1990s. Neurological …

Lewy body variant of Alzheimer's disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem

O Yokota, K Tsuchiya, T Uchihara, H Ujike… - …, 2007 - Wiley Online Library
Lewy bodies (LB) usually extend from the brainstem to the cerebrum in patients with
Parkinson's disease. However, whether the patterns of progression of LB and neuronal loss …